Lisa Henderson

Examining the incumbent and imminent workforce.

Latest disease-modifying market entrant for SMA addresses administration, access gaps.

Pharm Exec profiles five recent drug launches and announces winners of first annual APEX Awards.

Looking Back at 2003–2006.

Still plenty to learn about the virus even after year-plus long pandemic

Influenced by lessons from the playing field, former rugby athlete James Robinson, today president and CEO of Urovant Sciences, discusses the keys to establishing a high-performing team culture in biopharma—and the end-game wins in treatment gain and patient need.

Recent roundtable highlights need for biopharma to enter ESG conversation.

Past lessons, strong resolve, and complex coordination propel J&J’s vaccine efforts.

Building on a lifelong passion for biomedical research, and then its application in policy and health equity as a leader in various interconnected settings, Michelle McMurry-Heath, president and CEO of BIO, is uniquely positioned as a “translator” for science and social advocacy—and speaking stakeholders to action.